• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

其3'非翻译区中的顺式作用元件介导KRAS的转录后调控。

Cis-acting elements in its 3' UTR mediate post-transcriptional regulation of KRAS.

作者信息

Kim Minlee, Kogan Nicole, Slack Frank J

机构信息

Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA.

Institute for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA.

出版信息

Oncotarget. 2016 Mar 15;7(11):11770-84. doi: 10.18632/oncotarget.7599.

DOI:10.18632/oncotarget.7599
PMID:26930719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4914247/
Abstract

Multiple RNA-binding proteins and non-coding RNAs, such as microRNAs (miRNAs), are involved in post-transcriptional gene regulation through recognition motifs in the 3' untranslated region (UTR) of their target genes. The KRAS gene encodes a key signaling protein, and its messenger RNA (mRNA) contains an exceptionally long 3' UTR; this suggests that it may be subject to a highly complex set of regulatory processes. However, 3' UTR-dependent regulation of KRAS expression has not been explored in detail. Using extensive deletion and mutational analyses combined with luciferase reporter assays, we have identified inhibitory and stabilizing cis-acting regions within the KRAS 3' UTR that may interact with miRNAs and RNA-binding proteins, such as HuR. Particularly, we have identified an AU-rich 49-nt fragment in the KRAS 3' UTR that is required for KRAS 3' UTR reporter repression. This element contains a miR-185 complementary element, and we show that overexpression of miR-185 represses endogenous KRAS mRNA and protein in vitro. In addition, we have identified another 49-nt fragment that is required to promote KRAS 3' UTR reporter expression. These findings indicate that multiple cis-regulatory motifs in the 3' UTR of KRAS finely modulate its expression, and sequence alterations within a binding motif may disrupt the precise functions of trans-regulatory factors, potentially leading to aberrant KRAS expression.

摘要

多种RNA结合蛋白和非编码RNA,如微小RNA(miRNA),通过其靶基因3'非翻译区(UTR)中的识别基序参与转录后基因调控。KRAS基因编码一种关键的信号蛋白,其信使RNA(mRNA)含有异常长的3'UTR;这表明它可能受到一套高度复杂的调控过程的影响。然而,尚未详细探讨KRAS表达的3'UTR依赖性调控。通过广泛的缺失和突变分析结合荧光素酶报告基因检测,我们在KRAS 3'UTR中鉴定出了可能与miRNA和RNA结合蛋白(如HuR)相互作用的抑制性和顺式作用稳定区域。特别地,我们在KRAS 3'UTR中鉴定出一个富含AU的49个核苷酸的片段,它是KRAS 3'UTR报告基因抑制所必需的。该元件包含一个miR-185互补元件,并且我们表明miR-185的过表达在体外抑制内源性KRAS mRNA和蛋白。此外,我们鉴定出另一个49个核苷酸的片段,它是促进KRAS 3'UTR报告基因表达所必需的。这些发现表明,KRAS 3'UTR中的多个顺式调控基序精细地调节其表达,并且结合基序内的序列改变可能破坏反式调控因子的精确功能,从而可能导致KRAS表达异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/918c601f92ed/oncotarget-07-11770-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/bc203bdcd7de/oncotarget-07-11770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/3f2b2799fe79/oncotarget-07-11770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/89d843f21230/oncotarget-07-11770-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/44c8f95dfad5/oncotarget-07-11770-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/918c601f92ed/oncotarget-07-11770-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/bc203bdcd7de/oncotarget-07-11770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/3f2b2799fe79/oncotarget-07-11770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/89d843f21230/oncotarget-07-11770-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/44c8f95dfad5/oncotarget-07-11770-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec6a/4914247/918c601f92ed/oncotarget-07-11770-g005.jpg

相似文献

1
Cis-acting elements in its 3' UTR mediate post-transcriptional regulation of KRAS.其3'非翻译区中的顺式作用元件介导KRAS的转录后调控。
Oncotarget. 2016 Mar 15;7(11):11770-84. doi: 10.18632/oncotarget.7599.
2
The 3'-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein.p21WAF1信使核糖核酸的3'非翻译区是一个复合顺式作用序列,被来自乳腺癌细胞的核糖核酸结合蛋白所结合,包括HuR和聚(C)结合蛋白。
J Biol Chem. 2003 Jan 31;278(5):2937-46. doi: 10.1074/jbc.M208439200. Epub 2002 Nov 12.
3
The existence of a putative regulatory element in 3'-untranslated region of proto-oncogene HOX11's mRNA.原癌基因HOX11的信使核糖核酸3'非翻译区中一个假定调控元件的存在。
J Biochem Mol Biol. 2005 Jul 31;38(4):500-6. doi: 10.5483/bmbrep.2005.38.4.500.
4
Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins.在表皮生长因子受体mRNA的3'非翻译区鉴定出一种新型富含AU元件,该元件是受调控的RNA结合蛋白的作用靶点。
Mol Cell Biol. 2001 Mar;21(6):2070-84. doi: 10.1128/MCB.21.6.2070-2084.2001.
5
A 250-nucleotide UA-rich element in the 3' untranslated region of Xenopus laevis Vg1 mRNA represses translation both in vivo and in vitro.非洲爪蟾Vg1信使核糖核酸3'非翻译区中一个250个核苷酸富含UA的元件在体内和体外均抑制翻译。
RNA. 2001 Dec;7(12):1753-67.
6
Post-transcriptional regulation of ULBP1 ligand for the activating immunoreceptor NKG2D involves 3' untranslated region.ULBP1 配体对激活免疫受体 NKG2D 的转录后调控涉及 3'非翻译区。
Hum Immunol. 2011 Jun;72(6):470-8. doi: 10.1016/j.humimm.2011.03.005. Epub 2011 Mar 13.
7
Translating the Untranslated Region.翻译未翻译区域。
J Immunol. 2015 Oct 1;195(7):2963-71. doi: 10.4049/jimmunol.1500756.
8
Tumor protein D52 expression is post-transcriptionally regulated by T-cell intercellular antigen (TIA) 1 and TIA-related protein via mRNA stability.肿瘤蛋白D52的表达通过mRNA稳定性在转录后水平受T细胞细胞间抗原(TIA)1和TIA相关蛋白调控。
Biochem J. 2017 May 4;474(10):1669-1687. doi: 10.1042/BCJ20160942.
9
Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: similarities to retroviral RNA-protein interactions.一种赋予结缔组织生长因子/肥大软骨细胞特异性24(ctgf/hcs24)基因转录后抑制作用的RNA元件的鉴定:与逆转录病毒RNA-蛋白质相互作用的相似性
Oncogene. 2000 Sep 28;19(41):4773-86. doi: 10.1038/sj.onc.1203835.
10
Post-transcriptional regulation of glucose transporter-1 by an AU-rich element in the 3'UTR and by hnRNP A2.3'非翻译区富含AU元件及hnRNP A2对葡萄糖转运蛋白1的转录后调控
Biochem Biophys Res Commun. 2004 Jun 11;318(4):977-82. doi: 10.1016/j.bbrc.2004.04.128.

引用本文的文献

1
In Silico Identification of Dysregulated miRNAs Targeting Gene in Pancreatic Cancer.胰腺癌中靶向基因的失调微小RNA的计算机鉴定
Diseases. 2024 Jul 12;12(7):152. doi: 10.3390/diseases12070152.
2
The Roles of microRNA miR-185 in Digestive Tract Cancers.微小RNA miR-185在消化道癌症中的作用
Noncoding RNA. 2022 Oct 8;8(5):67. doi: 10.3390/ncrna8050067.
3
RNA stabilization by a poly(A) tail 3'-end binding pocket and other modes of poly(A)-RNA interaction.聚(A)尾 3'端结合口袋和其他聚(A)-RNA 相互作用模式对 RNA 的稳定作用。

本文引用的文献

1
MiR-185 is involved in human breast carcinogenesis by targeting Vegfa.miR-185 通过靶向 Vegfa 参与人类乳腺癌发生。
FEBS Lett. 2014 Nov 28;588(23):4438-47. doi: 10.1016/j.febslet.2014.09.045.
2
MicroRNA-mediated regulation of KRAS in cancer.微小RNA介导的癌症中KRAS基因的调控
J Hematol Oncol. 2014 Nov 30;7:84. doi: 10.1186/s13045-014-0084-2.
3
DoRiNA 2.0--upgrading the doRiNA database of RNA interactions in post-transcriptional regulation.DoRiNA 2.0——升级转录后调控中RNA相互作用的DoRiNA数据库。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abe6523. Epub 2021 Jan 7.
4
Interleukin-4 gene polymorphism (C33T) and the risk of the asthma: a meta-analysis based on 24 publications.白细胞介素-4 基因多态性(C33T)与哮喘风险:基于 24 篇文献的荟萃分析。
BMC Med Genet. 2020 Nov 23;21(1):232. doi: 10.1186/s12881-020-01169-w.
5
Plant 3' Regulatory Regions From mRNA-Encoding Genes and Their Uses to Modulate Expression.来自mRNA编码基因的植物3'调控区及其用于调节表达的用途。
Front Plant Sci. 2020 Aug 14;11:1252. doi: 10.3389/fpls.2020.01252. eCollection 2020.
6
The Nefarious Nexus of Noncoding RNAs in Cancer.非编码 RNA 在癌症中的可恶关联。
Int J Mol Sci. 2018 Jul 17;19(7):2072. doi: 10.3390/ijms19072072.
7
Non-coding RNA networks in cancer.癌症中的非编码RNA网络
Nat Rev Cancer. 2018 Jan;18(1):5-18. doi: 10.1038/nrc.2017.99. Epub 2017 Nov 24.
8
Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development.胰腺中高表达的 HuR 促进类似胰腺炎的炎症微环境,从而促进肿瘤发展。
Mol Cell Biol. 2018 Jan 16;38(3). doi: 10.1128/MCB.00427-17. Print 2018 Feb 1.
Nucleic Acids Res. 2015 Jan;43(Database issue):D160-7. doi: 10.1093/nar/gku1180. Epub 2014 Nov 21.
4
miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer.miR-185 通过直接靶向 E2F6 和 DNMT1 以及间接上调三阴性乳腺癌中的 BRCA1 来抑制肿瘤增殖。
Mol Cancer Ther. 2014 Dec;13(12):3185-97. doi: 10.1158/1535-7163.MCT-14-0243. Epub 2014 Oct 15.
5
miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.微小RNA-185通过靶向DNA甲基转移酶1/磷酸酶和张力蛋白同源物/蛋白激酶B信号通路抑制肝癌生长。
Am J Pathol. 2014 Aug;184(8):2355-64. doi: 10.1016/j.ajpath.2014.05.004. Epub 2014 Jun 6.
6
miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer.miR-185 是一个独立的预后因素,可抑制胃癌的肿瘤转移。
Mol Cell Biochem. 2014 Jan;386(1-2):223-31. doi: 10.1007/s11010-013-1860-y. Epub 2013 Oct 25.
7
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.starBase v2.0:从大规模 CLIP-Seq 数据中解码 miRNA-ceRNA、miRNA-ncRNA 和蛋白质-RNA 相互作用网络。
Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7. doi: 10.1093/nar/gkt1248. Epub 2013 Dec 1.
8
Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.转移相关的 miR-185 是早期肝细胞癌的一个潜在预后生物标志物。
Biomed Pharmacother. 2013 Jun;67(5):393-8. doi: 10.1016/j.biopha.2013.03.022. Epub 2013 Apr 18.
9
PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data.PROGmiR:一种利用公开可用数据识别多种癌症中预后性miRNA生物标志物的工具。
J Clin Bioinforma. 2012 Dec 28;2(1):23. doi: 10.1186/2043-9113-2-23.
10
SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer.在癌症萌芽时进行 SNP 检测:miRNA 和 miRNA 靶位多态性作为癌症的诊断和预后生物标志物。
Pharmacol Ther. 2013 Jan;137(1):55-63. doi: 10.1016/j.pharmthera.2012.08.016. Epub 2012 Sep 3.